Medicina
DEPARTAMENTO
Hospital Infanta Leonor
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Infanta Leonor (20)
2024
-
Effectiveness of Treatment Approaches in COVID-19 Pneumonia: A Comparative Evaluation between a Specialized Center and Conventional Hospitals
Healthcare (Switzerland), Vol. 12, Núm. 14
-
Impact of systemic therapies on SARS-CoV-2 antibody seroprevalence in patients with immune-mediated diseases
Medicina Clinica, Vol. 162, Núm. 10, pp. 470-476
2023
-
AB1352 Impact of Systemic Therapies on the Seroprevalence of Sars-Cov-2 in Patients with Immune-Mediated Diseases
Annals of the Rheumatic Diseases, Vol. 82, Núm. Suppl 1, pp. 1907.1-1907
-
COVID-19 Severity and Survival over Time in Patients with Hematologic Malignancies: A Population-Based Registry Study
Cancers, Vol. 15, Núm. 5
-
Seroprevalence of SARS-CoV-2 antibodies in patients with immune-mediated inflammatory diseases treated with biological and synthetic targeted therapies
Revista Chilena de Infectologia, Vol. 40, Núm. 6, pp. 618-625
2022
-
Early predictive risk factors for dimethyl fumarate-associated lymphopenia in patients with multiple sclerosis
Multiple Sclerosis and Related Disorders, Vol. 59
-
Incidence of COVID-19 in 902 Patients With Immunomediated Inflammatory Diseases Treated With Biologics and Targeted Synthetic Disease-Modifying Antirheumatic Drugs-Findings From the BIOCOVID Study
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, Vol. 28, Núm. 2, pp. e348-e352
-
Incidence of COVID-19 in 902 Patients With Immunomediated Inflammatory Diseases Treated With Biologics and Targeted Synthetic Disease-Modifying Antirheumatic Drugs—Findings From the BIOCOVID Study
JCR: Journal of Clinical Rheumatology, Vol. 28, Núm. 2, pp. e348-e352
2021
-
Impact of biological therapies on the immune response after pneumococcal vaccination in patients with autoimmune inflammatory diseases
Vaccines, Vol. 9, Núm. 3, pp. 1-12
-
Measuring Choroid Thickness as a Marker of Systemic Inflammation in Patients with Ankylosing Spondylitis
Journal of Clinical Rheumatology, Vol. 27, Núm. 8, pp. E307-E311
2020
-
AB0726 Choroidal Thickness Is a Biomarker a and Can Predict The Response to Treatment in Ankylosing Spondylitis
Annals of the Rheumatic Diseases, Vol. 79, Núm. Suppl 1, pp. 1657.1-1658
-
Choroidal Thickness Is a Biomarker Associated With Response to Treatment in Ankylosing Spondylitis
JCR: Journal of Clinical Rheumatology
-
Comparison of noninvasive cardiac test strategies for newly diagnosed chagas disease in a non-endemic zone
American Journal of Tropical Medicine and Hygiene, Vol. 103, Núm. 4, pp. 1480-1486
-
Evaluation of the immune response to hepatitis B vaccine in patients on biological therapy: results of the RIER cohort study
Clinical Rheumatology, Vol. 39, Núm. 9, pp. 2751-2756
-
Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: Lessons from a large population-based registry study
Journal of Hematology and Oncology, Vol. 13, Núm. 1
-
Three-Year Effectiveness of Dimethyl Fumarate in Multiple Sclerosis: A Prospective Multicenter Real-World Study
CNS Drugs, Vol. 34, Núm. 12, pp. 1275-1286
-
Tolerability and safety of dimethyl fumarate in relapsing multiple sclerosis: a prospective observational multicenter study in a real-life Spanish population
Journal of Neurology, Vol. 267, Núm. 8, pp. 2362-2371
2019
-
Antibody responses to influenza vaccine in patients on biological therapy: Results of RIER cohort study
Medicina Clinica, Vol. 153, Núm. 10, pp. 380-386
2018
-
Spanish National Hip Fracture Registry (SNHFR): a description of its objectives, methodology and implementation
Revista Espanola de Geriatria y Gerontologia, Vol. 53, Núm. 4, pp. 188-195
2016
-
Anti-JC virus seroprevalence in a Spanish multiple sclerosis cohort JC virus seroprevalence in Spain
Journal of the Neurological Sciences, Vol. 365, pp. 16-21